$AGSS
AMERIGUARD SECURITY SERVICES, INC.

2021 Q4 Form 10-Q Financial Statement

#000126246321000555 Filed on November 12, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2021 Q1
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.940K $9.350K $5.180K
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $50.00K
YoY Change
% of Gross Profit
Operating Expenses $3.940K $9.350K $5.180K
YoY Change
Operating Profit
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$3.940K -$9.350K -$5.180K
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$3.940K -$9.347K -$5.183K
YoY Change -56.3%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$1.153K -$136.80 -$75.79
COMMON SHARES
Basic Shares Outstanding 68.35M shares 68.35M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q4 2021 Q3 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00 $0.00
YoY Change
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $2.215M
Other Receivables
Total Short-Term Assets $0.00
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $132.8K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $0.00
Total Long-Term Assets $0.00 $0.00
Total Assets $0.00 $0.00
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $418.3K $960.00 $5.180K
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $10.60K $6.660K $30.82K
YoY Change -58.67%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $10.60K $6.660K $30.82K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $10.60K $6.660K $30.82K
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$10.06M
YoY Change 0.21%
Common Stock $68.35K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$10.60K -$6.656K -$30.82K
YoY Change
Total Liabilities & Shareholders Equity $0.00 $0.00
YoY Change

Cashflow Statement

Concept 2021 Q4 2021 Q3 2021 Q1
OPERATING ACTIVITIES
Net Income -$3.940K -$9.347K -$5.183K
YoY Change -56.3%
Depreciation, Depletion And Amortization $50.00K
YoY Change
Cash From Operating Activities -$4.900K -$9.210K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures $20.00K
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$500.0K
YoY Change
Cash From Investing Activities -$520.0K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 4.900K 9.210K
YoY Change
NET CHANGE
Cash From Operating Activities -4.900K -9.210K
Cash From Investing Activities -520.0K
Cash From Financing Activities 4.900K 9.210K
Net Change In Cash 0.000 0.000 $0.00
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$4.900K -$9.210K
Capital Expenditures $20.00K
Free Cash Flow -$24.90K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
68346042 shares
CY2021Q3 us-gaap Professional Fees
ProfessionalFees
8319 USD
CY2020Q3 us-gaap Professional Fees
ProfessionalFees
13283 USD
us-gaap Professional Fees
ProfessionalFees
14698 USD
us-gaap Professional Fees
ProfessionalFees
13283 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
0 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
0 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
0 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
0 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
0 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-21387 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-21387 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-25640 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-5183 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-30823 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-2847 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-33670 USD
CY2021Q3 hraa Forgiveness Of Related Party Debt
ForgivenessOfRelatedPartyDebt
36361 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-9347 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-6656 USD
us-gaap Net Income Loss
NetIncomeLoss
-17376 USD
us-gaap Net Income Loss
NetIncomeLoss
-21387 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
956 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
0 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-16420 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-21387 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
16420 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
21387 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
16420 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
21387 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 USD
CY2020Q4 us-gaap Cash
Cash
0 USD
CY2019Q4 us-gaap Cash
Cash
0 USD
CY2021Q3 us-gaap Cash
Cash
0 USD
CY2020Q3 us-gaap Cash
Cash
0 USD
us-gaap Interest Paid
InterestPaid
0 USD
us-gaap Interest Paid
InterestPaid
0 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
68346042 shares
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The most significant estimates relate to income taxes and contingencies. The Company bases its estimates on historical experience, known or expected trends, and various other assumptions that are believed to be reasonable given the quality of information available as of the date of these financial statements. The results of these assumptions provide the basis for making estimates about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Actual results could differ from these estimates.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p>
hraa Expenses Paid
ExpensesPaid
5700 USD
CY2021Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
5700 USD

Files In Submission

Name View Source Status
0001262463-21-000555-index-headers.html Edgar Link pending
0001262463-21-000555-index.html Edgar Link pending
0001262463-21-000555.txt Edgar Link pending
0001262463-21-000555-xbrl.zip Edgar Link pending
ex31.htm Edgar Link pending
ex32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
hraa-20210930.xsd Edgar Link pending
hraa-20210930_cal.xml Edgar Link unprocessable
hraa-20210930_def.xml Edgar Link unprocessable
hraa-20210930_lab.xml Edgar Link unprocessable
hraa-20210930_pre.xml Edgar Link unprocessable
hraa9302021q.htm Edgar Link pending
hraa9302021q_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending